Marks Group Wealth Management, Inc Novartis Ag Transaction History

Marks Group Wealth Management, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$92.27 - $101.54 $28,880 - $31,782	-313 Reduced 11.47%	2,417 $244,000
Q3 2023 Oct 30, 2023	BUY	$94.73 - $105.13 $56,174 - $62,342	593 Added 27.75%	2,730 $278,000
Q2 2023 Jul 19, 2023	BUY	$92.52 - $104.91 $197,715 - $224,192	2,137 New	2,137 $215,000
Q4 2022 Feb 06, 2023	BUY	$75.55 - $92.52 $237,680 - $291,067	3,146 New	3,146 $285,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $265,947 - $313,626	-3,185 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $3,825 - $4,627	-49 Reduced 1.52%	3,185 $301,000
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $7,721 - $8,554	-94 Reduced 2.82%	3,234 $281,000
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $22,498 - $25,325	278 Added 9.11%	3,328 $290,000
Q1 2020 Apr 23, 2020	BUY	$70.67 - $99.01 $22,614 - $31,683	320 Added 11.72%	3,050 $252,000
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $230,275 - $260,360	2,730 New	2,730 $258,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Marks Group Wealth Management, Inc with notifications on news.